Correlation Between Scisparc and Antibe Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scisparc and Antibe Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scisparc and Antibe Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scisparc and Antibe Therapeutics, you can compare the effects of market volatilities on Scisparc and Antibe Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scisparc with a short position of Antibe Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scisparc and Antibe Therapeutics.
Diversification Opportunities for Scisparc and Antibe Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Scisparc and Antibe is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Scisparc and Antibe Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antibe Therapeutics and Scisparc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scisparc are associated (or correlated) with Antibe Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antibe Therapeutics has no effect on the direction of Scisparc i.e., Scisparc and Antibe Therapeutics go up and down completely randomly.
Pair Corralation between Scisparc and Antibe Therapeutics
If you would invest 53.00 in Scisparc on November 4, 2024 and sell it today you would lose (9.00) from holding Scisparc or give up 16.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scisparc vs. Antibe Therapeutics
Performance |
| Timeline |
| Scisparc |
| Antibe Therapeutics |
Scisparc and Antibe Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scisparc and Antibe Therapeutics
The main advantage of trading using opposite Scisparc and Antibe Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scisparc position performs unexpectedly, Antibe Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antibe Therapeutics will offset losses from the drop in Antibe Therapeutics' long position.| Scisparc vs. Virax Biolabs Group | Scisparc vs. ZyVersa Therapeutics | Scisparc vs. Unicycive Therapeutics | Scisparc vs. Quoin Pharmaceuticals Ltd |
| Antibe Therapeutics vs. Biotron Limited | Antibe Therapeutics vs. biOasis Technologies | Antibe Therapeutics vs. Covalon Technologies | Antibe Therapeutics vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |